NuSirt Biopharma, a company founded by Michael Zemel in Knoxville several years ago, has announced plans to launch a clinical trial to determine if its patented technology is a potential treatment for non-alcoholic fatty liver disease and steatohepatitis. The start-up, now based in Nashville, still maintains its research facilities here. For more information about the trial plans, read the news release. For our three-part series on the company, here are the links: Part 1, Part 2, and Part 3.
"Pitch for Good: Tennessee Tough"
- Virtual Event
- Jan 25 2021
"2021 TVC National Summit"
- University of Tennessee, Knoxville
- Jun 02 2021
"LSTCON" - Life Science TN Annual Conference
- Westin Hotel, Nashville
- Nov 09 2021